# Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer

> **NCT03646409** · — · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 542 (actual)

## Conditions studied

- Venous Thromboembolism
- Esophagus Cancer
- Bleeding
- Chemotherapy Effect

## Interventions

- **OTHER:** Venous thromboembolic event, arterial thromboembolic event, bleeding events

## Key facts

- **NCT ID:** NCT03646409
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-11
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 542 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03646409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03646409, "Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03646409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*